Average Co-Inventor Count = 4.30
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Sanofi (19 from 1,456 patents)
2. Sanofi-Synthelabo (3 from 152 patents)
3. Sanofi-Aventis (2 from 389 patents)
4. Elf Sanofi (1 from 53 patents)
25 patents:
1. 7202267 - Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic
2. 7119086 - Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
3. 6673790 - Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
4. 6046341 - 3-spiro-indolin-2-one derivatives
5. 5994350 - 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin
6. 5849780 - 1-benzenesulfonyl-1-1,3-dihydroindol-2-one derivatives, their
7. 5728723 - 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation
8. 5726322 - 1-benzenesulfonyl-1,3-dihydroindol-2-one derivatives, their preparation
9. 5696145 - 1-benzyl-1,3-dihydroindol-2-one derivatives, their preparation and the
10. 5686624 - 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation
11. 5663431 - 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation
12. 5661169 - 1-benzyl-1,3-dihydro-2H-benzimidazol-2-one derivatives, their
13. 5618833 - 1-benzyl-1,3-dihydroindol-2-one derivatives, their preparation and the
14. 5585394 - 1-benzenesulfonyl-1,3-dihydro-2H-benzimidazol-2-one derivatives
15. 5284838 - Use of 2,2-dimethylchroman-3-ol derivatives in the treatment of asthma